Now showing items 1-3 of 3
Selective serotonin reuptake inhibitors (SSRIs) and breast cancer : a record linkage study
Evidence suggests that selective serotonin reuptake inhibitors (SSRIs, a class of antidepressant medications) may contribute to increased breast cancer risk by stimulating the secretion of prolactin, a potential tumour ...
Communicating Results of New Genomic Tests to Physicians
Background: New genomic tests are being developed to predict an individual’s risk of cancer recurrence by analyzing the expression of multiple genes. However, it is unclear how to report the test results so that they would ...
Molecular Stress Signaling in Breast Epithelial Cells
Breast cancer is a complex disease, whose etiology is not well understood. A number of factors have been found to contribute to its development. Psychological stress has been recognized as such a factor in epidemiological ...